Table A3.
Associations between diabetes risk and PA frequency, duration and volume.
| Model 1: Male | Model 2: Female | ||||
|---|---|---|---|---|---|
| OR | 95%CI | OR | 95%CI | ||
| Frequency | |||||
| VPA | |||||
| No activity | 0.00 | 0.00 | |||
| 1–2 d/w | 0.67 | 0.36, 1.23 | 0.61 | 0.33, 1.14 | |
| 3–5 d/w | 0.40 * | 0.17, 0.94 | 0.60 * | 0.37, 0.99 | |
| 6–7 d/w | 0.91 | 0.61, 1.35 | 0.62 * | 0.42, 0.90 | |
| MPA | |||||
| No activity | 0.00 | 0.00 | |||
| 1–2 d/w | 0.88 | 0.47, 1.63 | 0.87 | 0.56, 1.36 | |
| 3–5 d/w | 0.94 | 0.58, 1.54 | 0.72 | 0.48, 1.08 | |
| 6–7 d/w | 1.13 | 0.77, 1.66 | 0.83 | 0.60, 1.13 | |
| LPA | |||||
| No activity | 0.00 | 0.00 | |||
| 1–2 d/w | 0.63 | 0.28, 1.45 | 0.87 | 0.48, 1.58 | |
| 3–5 d/w | 1.88 | 0.92, 3.85 | 0.97 | 0.59, 1.59 | |
| 6–7 d/w | 0.84 | 0.59, 1.20 | 1.00 | 0.73, 1.35 | |
| Duration | |||||
| VPA | |||||
| No activity | 0.00 | 0.00 | |||
| 10–29 min/d | 0.36 | 0.08, 1.64 | 0.85 | 0.32, 2.26 | |
| 30–119 min/d | 1.26 | 0.67, 2.39 | 0.75 | 0.41, 1.38 | |
| 120–239 min/d | 0.40 * | 0.20, 0.78 | 0.51 * | 0.30, 0.89 | |
| ≥240 min/d | 0.75 | 0.49, 1.15 | 0.60 * | 0.41, 0.88 | |
| MPA | |||||
| No activity | 0.00 | 0.00 | |||
| 10–29 min/d | 1.14 | 0.62, 2.08 | 1.06 | 0.70, 1.62 | |
| 30–119 min/d | 1.06 | 0.67, 1.68 | 0.93 | 0.62, 1.41 | |
| 120–239 min/d | 1.31 | 0.83, 2.07 | 0.78 | 0.53, 1.14 | |
| ≥240 min/d | 0.76 | 0.46, 1.24 | 0.46 *** | 0.30, 0.73 | |
| LPA | |||||
| No activity | 0.00 | 0.00 | |||
| 10–29 min/d | 0.91 | 0.55, 1.50 | 0.77 | 0.49, 1.19 | |
| 30–119 min/d | 1.15 | 0.76, 1.76 | 1.11 | 0.78, 1.58 | |
| 120–239 min/d | 0.73 | 0.47, 1.14 | 1.10 | 0.75, 1.62 | |
| ≥240 min/d | 0.52 * | 0.29, 0.91 | 0.64 | 0.40, 1.03 | |
| Volume | |||||
| VPA | |||||
| No activity | 0.00 | 0.00 | |||
| 10–74 min/w | 0.26 | 0.03, 2.10 | 0.60 | 0.13, 2.72 | |
| 75–299 min/w | 1.06 | 0.44, 2.55 | 0.74 | 0.37, 1.49 | |
| ≥300 min/w | 0.69 | 0.47, 1.01 | 0.60 ** | 0.43, 0.83 | |
| MPA | |||||
| No activity | 0.00 | 0.00 | |||
| 10–149 min/w | 1.20 | 0.68, 2.14 | 1.04 | 0.70, 1.55 | |
| 150–299 min/w | 0.69 | 0.30, 1.57 | 0.47 * | 0.25, 0.88 | |
| ≥300 min/w | 1.07 | 0.74, 1.55 | 0.80 | 0.59, 1.08 | |
| LPA | |||||
| No activity | 0.00 | 0.00 | |||
| 10–105 min/w | 0.95 | 0.84, 1.55 | 0.76 | 0.49, 1.17 | |
| 106–525 min/w | 1.14 | 0.75, 1.75 | 1.11 | 0.78, 1.58 | |
| 526–1260 min/w | 0.73 | 0.47, 1.14 | 1.15 | 0.79, 1.68 | |
| >1260 min/w | 0.51* | 0.29, 0.91 | 0.59 * | 0.36, 0.97 | |
| MVPA | |||||
| No activity | 0.00 | 0.00 | |||
| 45–675 METs | 0.80 | 0.39, 1.61 | 1.06 | 0.69, 1.64 | |
| 676–2250 METs | 0.75 | 0.44, 1.28 | 0.90 | 0.56, 1.45 | |
| ≥2250 METs | 0.83 | 0.53, 1.30 | 0.56 *** | 0.42, 0.75 | |
Note: ORs were adjusted for age, gender, marital status, education, drinking, smoking and BMI level. *: p < 0.05; **: p < 0.01.; ***: p < 0.001.